Impact of 30-day prescribed opioid dose trajectory on fatal overdose risk: A population-based, statewide cohort study

[1]  Fiona M. Blyth,et al.  Five-Year Trajectories of Prescription Opioid Use , 2023, JAMA network open.

[2]  N. Nataraj,et al.  Longitudinal dose patterns among patients newly initiated on long-term opioid therapy in the United States, 2018 to 2019: an observational cohort study and time-series cluster analysis. , 2023, Pain.

[3]  Christopher M. Jones,et al.  CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 , 2022, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[4]  J. Glanz,et al.  Opioid Dose Trajectories and Associations With Mortality, Opioid Use Disorder, Continued Opioid Therapy, and Health Plan Disenrollment , 2022, JAMA network open.

[5]  B. Clothier,et al.  Comparative Effectiveness of Opioid Tapering or Abrupt Discontinuation vs No Dosage Change for Opioid Overdose or Suicide for Patients Receiving Stable Long-term Opioid Therapy , 2022, JAMA network open.

[6]  G. Xing,et al.  Long-term Risk of Overdose or Mental Health Crisis After Opioid Dose Tapering , 2022, JAMA network open.

[7]  N. Dasgupta,et al.  Association of Opioid Dose Reduction With Opioid Overdose and Opioid Use Disorder Among Patients Receiving High-Dose, Long-term Opioid Therapy in North Carolina , 2022, JAMA network open.

[8]  A. Winterstein,et al.  Trajectories of prescription opioid dose and risk of opioid-related adverse events among older Medicare beneficiaries in the United States: A nested case–control study , 2022, PLoS medicine.

[9]  J. Dusek,et al.  Comment from the Academic Consortium for Integrative Medicine & Health on the CDC Clinical Practice Guideline for Prescribing Opioids–United States, 2022 , 2022, Global advances in health and medicine.

[10]  A. Jerant,et al.  Association of Dose Tapering With Overdose or Mental Health Crisis Among Patients Prescribed Long-term Opioids. , 2021, JAMA.

[11]  K. Huybrechts,et al.  The Risk of Overdose With Concomitant Use of Z-Drugs and Prescription Opioids: A Population-Based Cohort Study. , 2021, The American journal of psychiatry.

[12]  Daniel M. Hartung,et al.  Patient outcomes following opioid dose reduction among patients with chronic opioid therapy. , 2021, Pain.

[13]  Stephen G. Henry,et al.  Assessing opioid overdose risk: A review of clinical prediction models utilizing patient-level data. , 2021, Translational research : the journal of laboratory and clinical medicine.

[14]  Stephen G. Henry,et al.  Using Prescription Drug Monitoring Program Data to Assess Likelihood of Incident Long-Term Opioid Use: a Statewide Cohort Study , 2021, Journal of General Internal Medicine.

[15]  C. Davis,et al.  Laws limiting prescribing and dispensing of opioids in the United States, 1989-2019. , 2020, Addiction.

[16]  S. Crystal,et al.  All-cause mortality among males living with and without HIV initiating long-term opioid therapy, and its association with opioid dose, opioid interruption and other factors. , 2020, Drug and alcohol dependence.

[17]  Daniel M. Hartung,et al.  Patient Outcomes Following Opioid Dose Reduction Among Patients with Chronic Opioid Therapy , 2020 .

[18]  J. Weiner,et al.  Predictive Modeling of Opioid Overdose Using Linked Statewide Medical and Criminal Justice Data. , 2020, JAMA psychiatry.

[19]  T. Maryon,et al.  Independent Validation in a Large Privately Insured Population of the Risk Index for Serious Prescription Opioid-Induced Respiratory Depression or Overdose. , 2020, Pain medicine.

[20]  D. Boudreau,et al.  Primary Care Opioid Taper Plans Are Associated with Sustained Opioid Dose Reduction , 2020, Journal of General Internal Medicine.

[21]  C. Brummett,et al.  Association of Opioid Overdose Risk Factors and Naloxone Prescribing in US Adults , 2019, Journal of General Internal Medicine.

[22]  J. Weiner,et al.  Predicting Opioid Overdose Deaths Using Prescription Drug Monitoring Program Data. , 2019, American journal of preventive medicine.

[23]  C. Delcher,et al.  Overlapping prescriptions of opioids, benzodiazepines, and carisoprodol: "Holy Trinity" prescribing in the state of Florida. , 2019, Drug and alcohol dependence.

[24]  M. Heo,et al.  Opioid Taper Is Associated with Subsequent Termination of Care: a Retrospective Cohort Study , 2019, Journal of General Internal Medicine.

[25]  Stanley Xu,et al.  Association Between Opioid Dose Variability and Opioid Overdose Among Adults Prescribed Long-term Opioid Therapy , 2019, JAMA network open.

[26]  G. Alexander,et al.  Reducing High-Dose Opioid Prescribing: State-Level Morphine Equivalent Daily Dose Policies, 2007-2017. , 2019, Pain medicine.

[27]  Jeremy C. Weiss,et al.  Evaluation of Machine-Learning Algorithms for Predicting Opioid Overdose Risk Among Medicare Beneficiaries With Opioid Prescriptions , 2019, JAMA network open.

[28]  Marion A. Coe,et al.  Buprenorphine Pharmacology Review: Update on Transmucosal and Long-acting Formulations , 2019, Journal of addiction medicine.

[29]  Stephen G. Henry,et al.  Patients' Experience With Opioid Tapering: A Conceptual Model With Recommendations for Clinicians. , 2019, The journal of pain : official journal of the American Pain Society.

[30]  D. Bell,et al.  Escalating Opioid Dose Is Associated With Mortality: A Comparison of Patients With and Without Opioid Use Disorder , 2019, Journal of addiction medicine.

[31]  G. Guy,et al.  Opioid Prescribing in the United States Before and After the Centers for Disease Control and Prevention's 2016 Opioid Guideline , 2018, Annals of Internal Medicine.

[32]  Inmaculada Hernandez,et al.  Exposure-Response Association Between Concurrent Opioid and Benzodiazepine Use and Risk of Opioid-Related Overdose in Medicare Part D Beneficiaries , 2018, JAMA network open.

[33]  Hhs Centers for Medicare Medicare Services.  Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program. Final rule. , 2018, Federal register.

[34]  G. Franklin,et al.  Patterns of Opioid Use and Risk of Opioid Overdose Death Among Medicaid Patients , 2017, Medical care.

[35]  C. Vick,et al.  Validation of a Screening Risk Index for Serious Prescription Opioid-Induced Respiratory Depression or Overdose in a US Commercial Health Plan Claims Database , 2017, Pain medicine.

[36]  J. Turner,et al.  Prescription Opioid Taper Support for Outpatients With Chronic Pain: A Randomized Controlled Trial. , 2017, The journal of pain : official journal of the American Pain Society.

[37]  April F. Mohanty,et al.  Development and evaluation of a record linkage protocol for Utah’s Controlled Substance Database , 2017, Health Informatics J..

[38]  K. Murray,et al.  Prescription of Long-Acting Opioids and Mortality in Patients With Chronic Noncancer Pain. , 2016, JAMA.

[39]  R. Chou,et al.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. , 2016, JAMA.

[40]  Dara Ganoczy,et al.  Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study , 2015, BMJ : British Medical Journal.

[41]  Christopher M. Jones,et al.  Defining risk of prescription opioid overdose: pharmacy shopping and overlapping prescriptions among long-term opioid users in medicaid. , 2015, The journal of pain : official journal of the American Pain Society.

[42]  Caleb Wiedeman,et al.  High-risk use by patients prescribed opioids for pain and its role in overdose deaths. , 2014, JAMA internal medicine.

[43]  T. Gomes,et al.  Opioid dose and drug-related mortality in patients with nonmalignant pain. , 2011, Archives of internal medicine.

[44]  B. Psaty,et al.  Opioid Prescriptions for Chronic Pain and Overdose , 2010, Annals of Internal Medicine.

[45]  Ivan P. Fellegi,et al.  A Theory for Record Linkage , 1969 .

[46]  Yu Wang,et al.  Machine Learning Based Opioid Overdose Prediction Using Electronic Health Records , 2019, AMIA.

[47]  R. Deyo,et al.  High-risk prescribing and opioid overdose: prospects for prescription drug monitoring program–based proactive alerts , 2018, Pain.

[48]  M. Valenstein,et al.  Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths , 2012 .